Theta burst stimulation followed by cognitive exercise promising treatment for depression in youth Dr. Kamal Kant Kohli27 March 2023 10:00 AM ISTCanada: The use of neurotechnological approaches may be promising for treating depression in youth, says a recent study published in the Journal of...
Alembic Pharma bags USFDA tentative nod for antidepressant drug Brexpiprazole Ruchika Sharma9 March 2023 11:15 AM ISTBrexpiprazole Tablets are indicated as an adjunctive therapy to antidepressants for the treatment of major depressive disorder and for treatment of...
CBT or second-generation antidepressants recommended for adults with MDD: ACP updated guideline Dr. Kamal Kant Kohli24 Jan 2023 10:15 AM ISTThe American College of Physicians (ACP) has issued an update of its guideline with clinical recommendations for nonpharmacologic and pharmacologic...
FDA Fast Tracks PH10 for Treatment of Major Depressive Disorder Dr. Kamal Kant Kohli28 Dec 2022 2:30 AM ISTAccording to a press release, the US Food and drug administration has granted fast track designation to a nasal spray PH10 for the treatment of major...
FDA Approves cariprazine as Adjunctive Treatment for Major Depressive Disorder Dr. Kamal Kant Kohli19 Dec 2022 10:00 AM ISTThe US Food and Drug Administration (FDA) has approved cariprazine (VRAYLAR) as an adjunctive therapy to antidepressants for the treatment of major...
Esketamine nasal spray found superior to quetiapine extended-release in resistant depression in phase 3 trial Dr. Kamal Kant Kohli30 Nov 2022 8:00 PM ISTEsketamine nasal spray was found superior to to quetiapine extended-release (XR) in adults with treatment-resistant major depressive disorder,...
Addition of Sleep deprivation to treatment of depression may not enhance outcomes Dr. Shravani Dali11 Nov 2022 8:00 PM ISTThe addition of sleep deprivation to treatment packages leads to enhanced depressive outcomes suggests a recent study published in the Sleep ...
Lupin rolls out Desvenlafaxine ER tablets in US Ruchika Sharma27 Aug 2022 9:30 AM ISTMumbai: Global pharma major, Lupin Limited, has announced the launch of Desvenlafaxine Extended-Release Tablets, 25 mg, having received an approval...
FDA approves first fast acting Oral drug for major depressive disorder Dr. Kamal Kant Kohli23 Aug 2022 9:00 AM ISTThe US Food and drug administration has approved an extended release combination of dextromethorphan and bupropion for adults with major depressive...
Abbott gets USFDA breakthrough device designation for deep brain stimulation system in depression Ruchika Sharma14 July 2022 5:27 PM ISTAbbott's DBS system is a personalized, adjustable therapy that involves implanting thin wires – or leads – into targeted areas of the brain.
Mediterranean diet helps to fight depression in young Dr.B.P.RAHUL18 May 2022 9:15 AM ISTYoung men with a poor diet saw a significant improvement in their symptoms of depression when they switched to a healthy Mediterranean diet, a new...
Anxiety and depression improved by self care preventing heart failure Dr. Nandita Mohan3 Feb 2022 5:30 PM IST Mental health is equally important in maintaining a healthy life. Heart failure is one of the major concerns and problems associated with...
